AstraZeneca

Will Vectura Group plc outperform AstraZeneca plc after today’s results gain a Brexit boost?

Is Vectura Group plc (LON: VEC) a more attractive buy than healthcare peer AstraZeneca plc (LON: AZN)? More »

Is Neil Woodford’s favourite stock set to outperform in 2017?

Neil Woodford loves this company, but should you be buying? More »

2 healthcare stocks that could make you rich in 2017

These two companies offer bright futures at fair valuations. More »

My 3 top dividend stocks for Christmas

Tucking away some tasty dividends for Christmas can help you to a prosperous New Year. More »

Why Eco Animal Health Group Plc is set to outperform AstraZeneca plc in 2017

Eco Animal Health Group Plc (LON: EAH) has more appeal than AstraZeneca plc (LON: EAH). More »

Why I believe these 3 stocks will struggle in 2017

These three companies are in danger of generating losses for investors next year. More »

3 cheap blue chips for December

Are these Footsie favourites now unmissable bargains? More »

4 dividend stocks to put on your 2017 shopping list

Royston Wild reveals a cluster of London stocks with exceptional dividend potential. More »

Is ReNeuron Group plc a better buy than AstraZeneca plc?

Should you ditch AstraZeneca plc (LON: AZN) in favour of ReNeuron Group plc (LON: RENE)? More »

These 3 FTSE 100 stocks are ridiculously cheap!

Royston Wild discusses three FTSE 100 (INDEXFTSE: UKX) dealing at rock-bottom prices. More »

Is AstraZeneca plc or GlaxoSmithKline plc the best Black Friday buy?

Will AstraZeneca plc (LON: AZN) or GlaxoSmithKline plc (LON: GSK) soar over the medium-to-long term? More »

Are these 2 stocks the income heroes your portfolio needs?

These two stocks pay income of more than 5% a year. Harvey Jones examines whether this rate of return is sustainable. More »

Should you dump AstraZeneca plc and buy BTG plc after 10% sales rise?

Does BTG plc (LON: BTG) offer superior growth potential to AstraZeneca plc (LON: AZN)? More »

Clinigen Group plc vs AstraZeneca plc: which is the hotter healthcare stock?

Royston Wild considers the investment potential of medicine mammoths Clinigen Group plc (LON: CLIN) and AstraZeneca plc (LON: AZN). More »

Why AstraZeneca plc may still not be cheap enough to beat this upstart

Roland Head takes a look at the latest figures from AstraZeneca plc (LON:AZN) and considers a potential alternative. More »

Should you invest in pills or joints?

Which of these stocks should be on your shopping list today? More »

2 firms to hold until you retire and beyond

Brexit looks like a sideshow for these enduring businesses. More »

These FTSE 100 stocks sank in October. Time to stock up?

Royston Wild runs the rule over two recent FTSE 100 (INDEXFTSE: UKX) losers. More »

The Good, the Bad and the Ugly of pharma stocks

Bilaal Mohamed reveals his best and worst picks from the pharmaceuticals sector. More »

Should you buy this stock after it reports a 27% rise in revenue?

Is this company set to soar after positive results? More »